STRO-4

N/A

Report date: 2025/12/19 20:01:35

Base Information

Drug NameSTRO-4

Drug Alias NameSTR04STR-04STRO4STRO-4

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsAmyotrophic Lateral Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNew England Cell Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNew England Cell Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A